Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NyQuil D behind the counter

This article was originally published in The Tan Sheet

Executive Summary

NyQuil Dis launching with the same pseudoephedrine-containing formula as the original Nyquil, but sold behind retail counters, Procter & Gamble announces Oct. 1. Part of the Vicks cough, cold and flu line, the 10 oz. formula carries an SRP of $6.32. P&G removed PSE from Vicks products due to illicit use of the ingredient and because the Combat Meth Act prohibits OTC sales of PSE products (1"The Tan Sheet" March 6, 2006, p. 5)...
Advertisement

Related Content

Pseudoephedrine Will Be Behind The Counter Across The Country By October
Pseudoephedrine Will Be Behind The Counter Across The Country By October

Topics

Advertisement
UsernamePublicRestriction

Register

PS100982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel